Alumis (ALMS) Total Liabilities (2023 - 2026)
Alumis (ALMS) posted quarterly Total Liabilities of $110.6 million for Q4 2025, up 36.79% year-over-year from $80.9 million in Q4 2024, and up 7.17% quarter-over-quarter from $103.2 million in Q3 2025.
Powered by 
Analysis
Alumis (ALMS) Total Liabilities (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Total Liabilities for 3 consecutive years, with $110.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities rose 36.79% year-over-year to $110.6 million; the TTM figure through Dec 2025 stood at $110.6 million (up 36.79% YoY), while the FY2025 annual figure was $110.6 million, up 36.79% from the prior year.
- Total Liabilities grew to $110.6 million in Q4 2025 per ALMS's latest filing, from $103.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $125.6 million in Q2 2025 and bottomed at $53.5 million in Q4 2023.
- Historically, Total Liabilities has averaged $87.0 million across 3 years, with a median of $86.9 million in 2024.
- On a YoY basis, Total Liabilities climbed as much as 94.13% in 2025 and fell as far as 36.79% in 2025.
- Alumis' Total Liabilities stood at $53.5 million in 2023, then jumped by 51.19% to $80.9 million in 2024, then jumped by 36.79% to $110.6 million in 2025.
- Business Quant data shows ALMS's Total Liabilities at $110.6 million in Q4 2025, $103.2 million in Q3 2025, and $125.6 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Alumis | 1.42 Bn | 919.00 Mn | - | 108.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.46 Mn |
| Dec 31, 2025 | 110.64 Mn |
| Sep 30, 2025 | 103.24 Mn |
| Jun 30, 2025 | 125.60 Mn |
| Mar 31, 2025 | 92.98 Mn |
| Dec 31, 2024 | 80.89 Mn |
| Sep 30, 2024 | 64.17 Mn |
| Jun 30, 2024 | 64.70 Mn |
| Mar 31, 2024 | 385.93 Mn |
| Dec 31, 2023 | 53.50 Mn |
| Sep 30, 2023 | 303.07 Mn |
| Jun 30, 2023 | 262.35 Mn |